Safety Study of AT1001 to Treat Celiac Disease.
Safety of AT-1001 in Healthy Volunteers
Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate (AT-1001) in Active Celiac Disease
Study of the Efficacy of AT1001 (Larazotide Acetate) to Treat Celiac Disease
Phase IIb Study to Study the Efficacy of AT1001 to Treat Celiac Disease
Safety and Tolerability Study of AT1001 in Celiac Disease Subjects
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
† Indicates status has not been verified in more than two years